Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-19-000192
Filing Date
2019-04-16
Accepted
2019-04-16 19:43:40
Documents
1
Period of Report
2019-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT prnb.html 3  
1 OWNERSHIP DOCUMENT prnb.xml 3 5348
  Complete submission text file 0000903423-19-000192.txt   7162
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-38871 | Film No.: 19751986
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations